US Dollar vs Yen

登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

登録

ホーム
投資
株式
アメリカ
NYSE
Teva Pharmaceutical Industries Ltd (TEVA)
Teva Pharmaceutical Industries Ltd (TEVA) ニュース

TEVA

Teva Pharmaceutical Indu... (TEVA)

Teva Pharmaceutical Industries Ltd

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NYSE:TEVA

<< 前へ 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2020/07/13	21 : 00	Business Wire	Teva Announces Availability of ProAir® Digihaler® (albuterol sulfate 117 mcg) Inhalation Powder for Patients with Asthma & ...	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2020/07/10	05 : 00	Business Wire	Teva to Host Conference Call to Discuss Second Quarter 2020 Financial Results at 8 a.m. ET on August 5, 2020	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2020/06/18	21 : 00	Business Wire	Teva Presents New Analyses Examining Changes in Migraine Disability Outcome Measurements with AJOVY® (fremanezumab-vfrm) Inj...	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2020/06/15	21 : 00	Business Wire	Teva to Present New Data on AJOVY® (fremanezumab-vfrm) Injection Open-Label Extension Study at American Headache Society Ann...	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2020/06/15	20 : 35	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2020/06/15	20 : 35	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2020/06/15	20 : 34	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2020/06/15	20 : 33	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2020/06/15	20 : 32	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2020/06/15	20 : 32	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2020/06/11	20 : 17	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2020/06/11	20 : 16	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2020/06/11	20 : 16	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2020/06/11	20 : 14	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2020/06/11	20 : 13	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2020/06/11	20 : 11	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2020/06/11	20 : 10	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2020/06/09	20 : 30	GlobeNewswire Inc.	NIRI Philadelphia Elects New Board Members	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2020/06/02	21 : 00	Business Wire	Teva Showcases Global Impact in 2019 Environmental, Social and Governance Progress Report	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2020/05/26	21 : 00	Business Wire	Teva Announces Virtual 2020 Annual Meeting of Shareholders	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2020/05/26	02 : 08	Business Wire	Teva präsentiert auf dem Kongress der Europäischen Akademie für Neurologie neue Daten zur Evaluierung der Erfahrungen von ...	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2020/05/25	23 : 53	Business Wire	Teva a présenté de nouvelles données lors du congrès de l'Académie européenne de neurologie évaluant l'expérience de ...	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2020/05/25	15 : 00	Business Wire	Teva Presented New Data at the European Academy of Neurology Congress Evaluating the AJOVY® (fremanezumab) Experience in Pop...	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2020/05/23	03 : 11	Business Wire	Teva präsentiert neue Analysen zu AJOVY® (Fremanezumab) und jüngste Daten zu COPAXONE® (Injektionslösung Glatirameraceta...	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2020/05/23	01 : 11	Business Wire	Teva va présenter de nouvelles analyses d'AJOVY® (fremanezumab) et les dernières données sur le COPAXONE® (acétate de g...	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2020/05/22	15 : 00	Business Wire	Teva to Present New AJOVY® (fremanezumab) Analyses & Latest COPAXONE® Data (glatiramer acetate injection) at European Acade...	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2020/05/18	20 : 00	Business Wire	China Approves AUSTEDO® For Treating Chorea Associated with Huntington's Disease and Tardive Dyskinesia in Adults	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2020/05/07	20 : 00	Business Wire	Teva Reports First Quarter 2020 Financial Results	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2020/05/04	21 : 00	Business Wire	Teva & Celltrion Healthcare Announce the Launch of TRUXIMA® (rituximab-abbs) Injection for Rheumatoid Arthritis, the Only Bi...	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2020/05/01	21 : 00	Business Wire	New Data For Teva AJOVY® (fremanezumab-vfrm) Injection and AUSTEDO® (deutetrabenazine) Tablets Included in Neurology	NYSE:TEVA	Teva Pharmaceutical Industries Ltd

Showing the most relevant articles for your search:NYSE:TEVA

<< 前へ 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 次へ >>

BNP Paribas (QX)

Deutsche Telekom (QX)

American Express

JP Morgan Chase

Invesco QQQ Trust Series 1

Financial Select Sector

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約